Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-27 @ 11:51 PM
Study NCT ID:
NCT00816660
Status:
COMPLETED
Last Update Posted:
2021-05-03
First Post:
2009-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Sponsor:
Baxalta now part of Shire
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-02
First Submit QC Date:
None
Study First Post Date:
2009-01-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-29
Last Update Post Date:
2021-05-03
Last Update Post Date Type:
ACTUAL